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Beau lines are transverse, band-like depressions 
extending from one lateral edge of the nail to the 
other and affecting all nails at corresponding levels 
(1). onychomadesis is considered an extreme form of 
Beau line with subsequent separation of the proximal 
nail plate from the nail bed. Both fall along a spectrum 
of nail plate abnormalities that occur secondary to 
temporary nail matrix arrest (NMA). Various systemic 
and dermatologic conditions have been reported in 
association with onychomadesis (2-7) (table 1). Nail 
changes can affect all or some of the nails and both 
the fingernails and toenails; however, fingernails are 
more frequently affected. the severity of the nail 
changes varies depending on the underlying cause, 
its duration, and environmental factors (8). We pres-
ent a case of onychomadesis following cutaneous 
leukocytoclastic vasculitis (CLCV).
A 61-year-old woman presented to the Dermatol-
ogy Clinic complaining of a purpuric rash that began 
on her lower extremities and rapidly progressed to 
her abdomen and upper extremities over the previ-
ous five days. her medical history was remarkable for 
hypertension and diet-controlled diabetes mellitus. 
her medications included enalapril, which she had 
been taking for the past four years. on three consecu-
tive days before the skin eruption, the patient took 
oral diclofenac sodium for hip pain.
A clinical examination revealed non-blanching 
petechial rash on the legs, abdomen, and upper limbs 
up to the elbow (Figure 1, A) with leukocytoclastic 
vasculitis on biopsy (Figure 1, B). Direct immunofluo-
rescence was negative. 
Laboratory investigations revealed a white blood 
cell count of 14.5 × 109/L with a normal differential 
count, and a platelet count of 380 × 109/L. Westergren 
erythrocyte sedimentation rate was 65 mm/1st h, 
and C reactive protein was at 8.5 mg/dL. Antinuclear 
antibodies, rheumatoid factor, immune complexes, 
and cryoglobulinemia were negative, as were B and 
C hepatitis virus serological tests. her renal, cardiac, 
pulmonary, and abdominal exams were normal. Di-
clofenac was discontinued due to a clinical suspicion 
of drug-induced cutaneous vasculitis. the rash re-
solved in 2 weeks without treatment, leaving post-in-
flammatory hyperpigmentation.
Table 1. Causes and associations of onychomadesis
hand-foot-mouth disease (Coxsackie virus A)
Varicella
Fungal nail infection
Drugs (antineoplastic agents, azitromycin, retinoids, penicillin, valproic acid)
Local inflammation (trauma, acute paronychia, pyogenic granuloma)




Severe systemic insult (fever, systemic diseases, renal failure, peritoneal dialysis, Kawasaki’s disease, infection)
Bullous dermatoses (pemphigus, pemphigoid)
Cronkhite-Canada syndrome
idiopathic familial onychomadesis
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Four weeks later, she presented with painless, 
palpable grooves on all 10 fingernails (Figure 2). the 
grooves were 3 to 4 mm in width, at a similar distance 
from the proximal nail fold. there were no signs of 
periungual inflammation. the patient denied any re-
cent history of trauma, unusual activities, or chemical 
exposure. routine serum biochemistry and hematol-
ogy results were normal. repeated potassium hy-
droxide preparations and fungal cultures of the nail 
clippings were negative. A diagnosis of Beau lines 
and onychomadesis was made. Nail changes were 
tolerable and did not require any specific treatment.
During the follow up, the Beau lines advanced 
with the linear growth of the nails and disappeared 
(Figure 3 and 4). Four fingernails developed complete 
nail shedding (onychomadesis). No toenail alterations 
were observed in this period. A complete recovery of 
the nail plate surface was observed after 4 months.
the nail matrix epithelium is formed by highly pro-
liferating cells that differentiate and keratinize to pro-
duce the nail plate. the nail matrix epithelium is very 
susceptible to toxic noxae, and acute damage results 
in a defective nail plate formation. Nail matrix arrest 
is a term used to describe a temporary inhibition of 
the nail matrix proliferation that can present as Beau 
lines and onychomadesis (8). the width of Beau lines 
relates to the duration of the etiological agent. As the 
nail adheres firmly to the nail bed, the onychomade-
sis remains latent for several weeks before leading to 
temporary shedding (8,9).
there are several proposed etiological mecha-
nisms for NMA. NMA associated with fever, severe in-
fection, and major medical illnesses can be explained 
by an inflammation of the matrix, periungual tissues, 
or digital blood vessels (8); chemotherapy agents 
Figure 1. (A) Palpable purpura and hemorrhagic bullae on 
both lower extremities. (B) Leukocytoclastic vasculitis: en-
dothelial swelling, leukocytoclasis, and extravasation of red 
blood cells (hematoxylin and eosin ×200).
Figure 2. (A) transverse deep grooves in the nail plate par-
allel to the lunula (Beau Lines) are present 7 weeks after 
onset of drug-induced leukocytoclastic vasculitis. (B) ony-
chomadesis affecting thumbnails on the same level. Note 
that the periungual tissue is normal. 
Figure 3. During the follow-up, the Beau lines advanced 
with the linear growth of the nails.
Figure 4. After 3 months of cutaneous vasculitis, recovery 
of the nail plate surface was almost complete.
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temporary inhibit the mitotic activity in nail matrix 
(10); the detection of Coxackie virus in the shedding 
nail particle, following hand, foot, and mouth disease, 
suggests that the viral replication itself may directly 
damage the nail matrix (11). however, as nail chang-
es are not unique, it may be difficult to incriminate a 
single etiological agent.
our patient presented with an onset of Beau lines 
seven weeks after the initial CLCV lesions, which sug-
gests that vasculitis might have acted as a trigger for 
NMA. As the fingers were not affected by CLCV, an in-
direct effect of vasculitis is more plausible.
Leukocytoclastic vasculitis is a small-vessel inflam-
matory disease mediated by a deposition of immune 
complexes. thus, the circulating immune complexes 
may be involved in the damage of nail bed microvas-
culature. 
Considering that the patient had been receiving 
enalapril and diclofenac, it is less likely that those 
drugs were involved in the pathogenesis of NMA. 
enalapril was continued, and the nail changes were 
resolved while patient was still on enalapril. Further-
more, diclofenac is a widely prescribed drug and its 
association with NMA is yet to be described in litera-
ture.
We described a patient who developed Beau lines 
and onychomadesis following cutaneous leukocyto-
clastic vasculitis. this clinical observation can expand 
the spectrum of possible causes of nail matrix arrest. 
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